Microsoft to Buy Rosetta Biosoftware to Integrate -Omics Analysis Tools into New Amalga Platform
June 05, 2009
Microsoft to Buy Rosetta Biosoftware to Integrate -Omics Analysis Tools into New Amalga Platform
Broadening its footprint in life sciences, Microsoft will buy "certain assets" of Rosetta Biosoftware, including its Resolver, Elucidator, and Syllego software packages.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Ceiba Hires Former Rosetta Biosoftware Staffers After Landing Support Contract for Its Customers
December 11, 2009 / BioInform - Microsoft Stops Sale of Rosetta Biosoftware Tools, Support Will End by 2011
July 7, 2009 / BioInform - Microsoft Takes Aim at Life-Sci Community with New Platform and New Partnerships
May 1, 2009 / BioInform - Merck Sees Promise for Mass Spec-Based Protein Biomarker Pipeline in Drug Development
October 8, 2010 / ProteoMonitor - Downloads and Upgrades
November 19, 2010 / BioInform